Quintiles Transnational Holdings Inc (Q)

79.01
0.40 0.50
NYSE : Health Care
Prev Close 79.41
Open 79.20
Day Low/High 78.42 / 79.34
52 Wk Low/High 55.01 / 79.78
Volume 625.29K
Avg Volume 1.12M
Exchange NYSE
Shares Outstanding 118.48M
Market Cap 9.26B
EPS 3.10
P/E Ratio 23.53
Div & Yield N.A. (N.A)

Latest News

IMS Health Announces Pricing On Upsized Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Announces Pricing On Upsized Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Holdings, Inc. (NYSE:IMS) today announced the pricing of its offering of $1.

IMS Health Announces Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Announces Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.

IMS Health Announces Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Announces Offering Of Senior Notes In Connection With Quintiles IMS Merger

IMS Health Holdings, Inc. (NYSE:IMS) today announced that its wholly owned subsidiary, IMS Health Incorporated, intends to raise $1.

John Paulson Bought These 5 Stocks -- but the Charts Say Sell

John Paulson Bought These 5 Stocks -- but the Charts Say Sell

How does technical analysis stack up to John Paulson's stock picking strategy?

IMS Health And Quintiles Announce Key Officers For Merged Company

IMS Health And Quintiles Announce Key Officers For Merged Company

IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc.

IMS Health And Quintiles Announce Key Officers For Merged Company

IMS Health And Quintiles Announce Key Officers For Merged Company

IMS Health Holdings, Inc. (NYSE:IMS) and Quintiles Transnational Holdings Inc.

10 Stocks Billionaire John Paulson Is Buying for 2016

10 Stocks Billionaire John Paulson Is Buying for 2016

Here are 10 stocks hedge fund manager John Paulson has been buying lately, either initiating new stakes or upping his holdings significantly.

Quintiles-DaVita Infographic (Graphic: Business Wire)

Quintiles-DaVita Infographic (Graphic: Business Wire)

Quintiles, the world's largest provider of product development and integrated healthcare services, and DaVita Clinical Research, a wholly-owned subsidiary of DaVita HealthCare Partners Inc.

Microsoft-LinkedIn Deal Fuels 2Q Tech M&A Rebound

Microsoft-LinkedIn Deal Fuels 2Q Tech M&A Rebound

Joe Atkinson, a technology, infocomm, entertainment and media advisory leader at PricewaterhouseCoopers, says its all fueled by access to markets and consumers.

3 Stocks Pushing The Health Services Industry Higher

3 Stocks Pushing The Health Services Industry Higher

TheStreet highlights 3 stocks pushing the health services industry higher today.

Quintiles Transnational Holdings (Q) Is Weak On High Volume Today

Quintiles Transnational Holdings (Q) Is Weak On High Volume Today

Trade-Ideas LLC identified Quintiles Transnational Holdings (Q) as a weak on high relative volume candidate

Quintiles 2nd Quarter 2016 Results

Quintiles 2nd Quarter 2016 Results

Quintiles Transnational Holdings Inc. ("Quintiles" or the "Company") (NYSE: Q) today reported its financial results for the quarter ended June 30, 2016.

Quintiles' Second Quarter 2016 Earnings Call Scheduled For Wednesday, July 27th

Quintiles' Second Quarter 2016 Earnings Call Scheduled For Wednesday, July 27th

Quintiles Transnational Holdings Inc. (NYSE: Q) will release its second quarter 2016 financial results Wednesday, July 27, 2016 prior to its quarterly earnings call at 8:00 a.

Quintiles Transnational Holdings (Q) Stock Storming The Castle Today

Quintiles Transnational Holdings (Q) Stock Storming The Castle Today

Trade-Ideas LLC identified Quintiles Transnational Holdings (Q) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate

Healthcare Opportunities in Light of Brexit-Driven Selloff

Healthcare Opportunities in Light of Brexit-Driven Selloff

The sharp declines seen across the healthcare sector could present buying opportunities in companies such as Aetna, HCA, Icon and Paraxel.

Quintiles Introduces Continuous Glucose Monitoring Services To Improve Diabetes Outcomes

Quintiles Introduces Continuous Glucose Monitoring Services To Improve Diabetes Outcomes

Quintiles today announced the launch of its new Continuous Glucose Monitoring (CGM) service offering.

Q2 Solutions CEO Costa Panagos(Photo: Business Wire)

Q2 Solutions CEO Costa Panagos(Photo: Business Wire)

Q 2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award.

Quintiles Has Opened Its Global Solution Design Studio Where Expert Teams Will Collaborate To Create Technology Solutions That Tackle Some Of Healthcare's Biggest Challenges.

Quintiles Has Opened Its Global Solution Design Studio Where Expert Teams Will Collaborate To Create Technology Solutions That Tackle Some Of Healthcare's Biggest Challenges.

Quintiles, the world's largest provider of product development and integrated healthcare services, has opened its global Solution Design Studio where expert teams will collaborate to create technology solutions that tackle...

CORRECTING and REPLACING Quintiles Recognized as Industry Leader for Phase I, Phase II/III and Phase IV Services

CORRECTING and REPLACING Quintiles Recognized as Industry Leader for Phase I, Phase II/III and Phase IV Services

Headline of release should read: Quintiles Recognized as Industry Leader for Phase I, Phase II/III and Phase IV Services (instead of Quintiles Recognized as Industry Leader for Phase I, Phase II/II and Phase IV Services).

Tom Pike, CEO, Quintiles (Photo: Business Wire)

Tom Pike, CEO, Quintiles (Photo: Business Wire)

Quintiles CEO Tom Pike will present at the Jefferies 2016 Healthcare Conference on Tuesday, June 7, 2016 in New York City at the Grand Hyatt New York.

Quintiles' Precision Enrollment Offering Is Designed To Significantly Accelerate Site Start-up And Patient Recruitment In Oncology Clinical Trials.

Quintiles' Precision Enrollment Offering Is Designed To Significantly Accelerate Site Start-up And Patient Recruitment In Oncology Clinical Trials.

Quintiles, the world's largest provider of product development and integrated healthcare services, today announced its Precision Enrollment offering.

Quintiles Transnational (Q) Stock Receives Rating Downgrade At Wells Fargo

Quintiles Transnational (Q) Stock Receives Rating Downgrade At Wells Fargo

Quintiles Transnational (Q) stock is lower Thursday morning as Wells Fargo downgraded it to 'market perform,' while doubting the company's IMS merger.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AHH, ARCC, ATU, BCRH, BFS, CFNB, FCE.A, FCE.B, FINL, HLF, LSCC, Q, RBC, SLRC, SNHY, WD Downgrades: BH, IVR, MTRN, PMC, TREE, TUP Initiations: EGRX, SEDG Read on to get TheStreet Quant Ratings' detailed report:

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Jim Cramer's 'Mad Money' Recap: Here's This Week's Game Plan

Cramer says he's looking forward to another week of earnings to see which bull markets are alive and well.

Jim Cramer's Top Takeaways: Martin Marietta Materials, Quintiles, AmerisourceBergen

Jim Cramer's Top Takeaways: Martin Marietta Materials, Quintiles, AmerisourceBergen

Cramer says Martin Marietta Materials has a bright future but to stay away from AmerisourceBergen.

IMS HEALTH HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Quintiles Transnational Holdings, Inc.

IMS HEALTH HOLDINGS, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate Sale To Quintiles Transnational Holdings, Inc.

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of IMS Health...

Quintiles Closes Down After $9B Bet on Data Collection

Quintiles Closes Down After $9B Bet on Data Collection

The acquisition would bring together two of the largest providers of data and services to the pharmaceuticals industry.